A Boireau Selected Research

9- carboxymethyl- 4- oxo- 5H,10H- imidazo(1,2- a)indeno(1,2- e)pyrazin- 2- phosphonic acid

10/2001

RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Boireau Research Topics

Disease

3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2001 - 12/2000
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2001
1	Epilepsy (Aura) 05/2001
1	Parkinson Disease (Parkinson's Disease) 04/2000

Drug/Important Bio-Agent (IBA)

3	Glutamic Acid (Glutamate)FDA Link 10/2001 - 12/2000
2	AMPA Receptors (AMPA Receptor)IBA 05/2001 - 12/2000
2	Glutamate Receptors (Glutamate Receptor)IBA 05/2001 - 12/2000
1	9- carboxymethyl- 4- oxo- 5H,10H- imidazo(1,2- a)indeno(1,2- e)pyrazin- 2- phosphonic acidIBA 10/2001
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 10/2001
1	Excitatory Amino Acid AntagonistsIBA 10/2001
1	Riluzole FDA LinkGeneric 04/2000
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 04/2000